MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

NeoGenomics Inc

Închisă

9.16 1.78

Rezumat

Modificarea prețului

24h

Curent

Minim

8.97

Maxim

9.45

Indicatori cheie

By Trading Economics

Venit

-19M

-45M

Vânzări

13M

181M

Marjă de profit

-24.867

Angajați

2,200

EBITDA

-41M

-48M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+18.16% upside

Dividende

By Dow Jones

Următoarele câștiguri

28 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

344M

1.2B

Deschiderea anterioară

7.38

Închiderea anterioară

9.16

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 sept. 2025, 14:35 UTC

Principalele dinamici ale pieței

Robo.ai Shares Rise After $300 Million Investment From Burkhan Capital

7 oct. 2025, 15:15 UTC

Market Talk

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

7 oct. 2025, 12:33 UTC

Achiziții, Fuziuni, Preluări

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7 oct. 2025, 12:32 UTC

Achiziții, Fuziuni, Preluări

NYSE Owner to Invest Up to $2 Billion in Polymarket -- WSJ

7 oct. 2025, 11:53 UTC

Market Talk

Central Banks Could Add Bitcoin to Reserves -- Market Talk

7 oct. 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 oct. 2025, 07:00 UTC

Market Talk

Bitcoin Eases After Hitting Fresh Record High -- Market Talk

6 oct. 2025, 10:14 UTC

Market Talk

Bitcoin Could Extend Gains on U.S. Government Shutdown -- Market Talk

6 oct. 2025, 07:18 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6 oct. 2025, 07:18 UTC

Market Talk

Bitcoin Stays Stronger After Hitting Record High -- Market Talk

3 oct. 2025, 13:10 UTC

Market Talk

Bitcoin Looks Ripe For Fresh Record High -- Market Talk

3 oct. 2025, 07:20 UTC

Market Talk

Bitcoin Pulls Back as Government Shutdown Delays Key Data -- Market Talk

2 oct. 2025, 13:17 UTC

Achiziții, Fuziuni, Preluări

Bitcoin Depot: Acquisition Had No Material Impact on Reported 3Q Preliminary Results >BTM

2 oct. 2025, 13:16 UTC

Achiziții, Fuziuni, Preluări

Bitcoin Depot: Acquisition Brings U.S. Market Share to Roughly 30% >BTM

2 oct. 2025, 13:16 UTC

Achiziții, Fuziuni, Preluări

Bitcoin Depot: Acquisition Adds Over 500 Kiosks to Network >BTM

2 oct. 2025, 13:15 UTC

Achiziții, Fuziuni, Preluări

Bitcoin Depot Acquires Assets of National Bitcoin ATM, Significantly Expanding U.S. Footprint

2 oct. 2025, 07:05 UTC

Market Talk

Global Equities Roundup: Market Talk

2 oct. 2025, 07:05 UTC

Market Talk

Bitcoin Rises Following Wall Street Rally -- Market Talk

1 oct. 2025, 23:12 UTC

Achiziții, Fuziuni, Preluări

Avalanche Treasury CEO is Bart Smith

1 oct. 2025, 23:11 UTC

Achiziții, Fuziuni, Preluări

Avalanche Treasury Investors Include Dragonfly, VanEck, Galaxy Digital and Others

1 oct. 2025, 23:07 UTC

Achiziții, Fuziuni, Preluări

Avalanche Treasury Plans to Own More Than $1B Worth of AVAX After Becoming a Public Company

1 oct. 2025, 23:06 UTC

Achiziții, Fuziuni, Preluări

Avalanche Treasury Co. Has an Exclusive Relationship With Avalanche Foundation

1 oct. 2025, 23:04 UTC

Achiziții, Fuziuni, Preluări

Avalanche Treasury: Transaction Includes About $460M in Treasury Assets

1 oct. 2025, 14:01 UTC

Market Talk

Bitcoin Rises as Weak Jobs Data Boost Rate-Cut Bets -- Market Talk

1 oct. 2025, 07:27 UTC

Market Talk

Bitcoin Edges Lower as U.S. Government Shut Down Begins -- Market Talk

30 sept. 2025, 14:20 UTC

Principalele dinamici ale pieței

Robo.ai Shares Rise After $300M Investment From Burkhan Capital

30 sept. 2025, 06:51 UTC

Market Talk

Bitcoin Eases as Possible U.S. Government Shutdown Looms -- Market Talk

29 sept. 2025, 13:48 UTC

Market Talk

Seasonality Could Favor Bitcoin in Coming Months -- Market Talk

29 sept. 2025, 07:40 UTC

Market Talk

Bitcoin Recovers But Remains at Risk of Renewed Losses -- Market Talk

26 sept. 2025, 07:29 UTC

Market Talk

Bitcoin Stabilizes After Steep Falls; Focus Turns to U.S. PCE Data -- Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

18.16% sus

Prognoză pe 12 luni

Medie 10.67 USD  18.16%

Maxim 14 USD

Minim 8 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

5

Cumpărare

6

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

7.7 / 10.27Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat